Elara had already factored in approximately $20 million in revenue from gAbraxane in the US for FY26. While 3–4 generic players are currently active in the market and the overall size has eroded, ...

Bristol Myers Squibb Co. closed 20.32% short of its 52-week high of $63.33, which the company achieved on March 11th.

With data as of April 9, 2025, we examine if Bristol-Myers Squibb Company(BMY) is consistently building momentum based on ...

Bristol-Myers Squibb Company (BMY) is currently at $50.78, down $2.96 or 5.5% --Would be lowest close since Sept. 26, 2024, when it closed at $50.12 --On pace for largest percent decrease since April ...

Bearish flow noted in Bristol Myers ( BMY) Squibb with 7,624 puts trading, or 1.4x expected. Most active are 5/2 weekly 50 puts and May-25 65 calls, with total volume in those strikes near 5,500 ...

The threat of tariffs has put the pharma industry through the wringer this week. On Wednesday, a week after instituting widespread tariffs and a day after promising that “major” tariffs were headed ...

To name a few, Johnson & Johnson, Merck & Co., and Bristol Myers Squibb are all top NJ-based industry names with broad export footprint in China.

Twin Capital Management upped its stake in Bristol-Myers Squibb by 11.2% in Q4, grabbing 92,094 shares valued over $5.2 ...

Walmart, Apple, Tesla, and Nvidia shares jump after President Donald Trump says he will be delaying tariffs above 10% on some ...

We recently published a list of the 10 High Growth Dividend Paying Stocks to Invest in. In this article, we are going to take ...

Bristol-Myers Squibb Co. got dismissal of a lawsuit alleging the company used reverse-payment agreements to delay the generic ...

The stock market mounted one of its biggest rallies in history after President Donald Trump announced a pause in some of his "reciprocal" tariffs on the globe, causing a market that has been under ...